Prognostic factors of overall survival after laser interstitial thermal therapy in patients with glioblastoma

Photonics and Lasers in Medicine

Volumn 3, Issue 2, 2014, Pages 143-150

  Missios, Symeon ^a   Schroeder, Jason L ^a   Barnett, Gene H ^a   Mohammadi, Alireza M ^a  

^a Rose Ella Burkhardt Brain Tumor and Neuro Oncology Center Department of Neurosurgery Neurological and Taussig Cancer Institutes ^*  (United States)

Author keywords

Glioblastoma; Laser ablation; LITT; NeuroBlate System

Indexed keywords

LASER ABLATION; REGRESSION ANALYSIS; TUMORS; VOLUMETRIC ANALYSIS;

COX REGRESSION ANALYSIS; GLIOBLASTOMA MULTIFORME; GLIOBLASTOMAS; INTRACRANIAL TUMORS; LASER INTERSTITIAL THERMAL THERAPIES; LITT; MINIMALLY-INVASIVE TECHNIQUE; PROGRESSION FREE SURVIVAL;

PATIENT TREATMENT;

BEVACIZUMAB; LOMUSTINE; TEMOZOLOMIDE;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN NECROSIS; BRAIN VENTRICULITIS; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEATING; HUMAN; LASER INTERSTITIAL THERMAL THERAPY; LOW LEVEL LASER SYSTEM; LOW LEVEL LASER THERAPY; MALE; MEDICAL DEVICE COMPLICATION; NEODYMIUM YAG LASER; OVERALL SURVIVAL; PATIENT SAFETY; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEIZURE; STAPHYLOCOCCUS INFECTION; TUMOR VOLUME; VOLUMETRY;

EID: 84903574820     PISSN: 21930635     EISSN: 21930643     Source Type: Journal    
DOI: 10.1515/plm-2013-0051     Document Type: Article

References (20)

1. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95(2):190-8. (Pubitemid 32799739)
2. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011;115(1):3-8.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352(10):987-96.
4. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ; ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7(5):392-401.
5. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T; ALA-Glioma Study Group. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62(3):564-76; discussion 564-76.
6. Barnett GH. The role of image-guided technology in the surgical planning and resection of gliomas. J Neurooncol 1999;42(3):247-58. (Pubitemid 29322201)
7. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 2011;12(11):997-1003.
8. Barker 2nd FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998;42(4):709-20; discussion 720-3.
9. Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott MW, Berger MS, Larson DA. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2007;69(3):825-30. (Pubitemid 47418399)
10. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998;40(2):287-95. (Pubitemid 28114370)
11. Ulm 3rd AJ, Friedman WA, Bradshaw P, Foote KD, Bova FJ. Radiosurgery in the treatment of malignant gliomas: the University of Florida experience. Neurosurgery 2005;57(3):512-7; discussion 512-7.
12. Bown SG. Phototherapy in tumors. World J Surg 1983;7(6):700-9.
13. De Poorter J. Noninvasive MRI thermometry with the proton resonance frequency method: study of susceptibility effects. Magn Reson Med 1995;34(3):359-67.
14. Sloan AE, Ahluwalia MS, Valerio-Pascua J, Manjila S, Torchia MG, Jones SE, Sunshine JL, Phillips M, Griswold MA, Clampitt M, Brewer C, Jochum J, McGraw MV, Diorio D, Ditz G, Barnett GH. Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg 2013;118(6):1202-19.
15. Schwarzmaier HJ, Eickmeyer F, von Tempelhoff W, Fiedler VU, Niehoff H, Ulrich SD, Yang Q, Ulrich F. MR-guided laserinduced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. Eur J Radiol 2006;59(2):208-15. (Pubitemid 44093175)
16. Sugiyama K, Sakai T, Fujishima I, Ryu H, Uemura K, Yokoyama T. Stereotactic interstitial laser-hyperthermia using Nd-YAG laser. Stereotact Funct Neurosurg 1990;54-55:501-5.
17. Kahn T, Bettag M, Ulrich F, Schwarzmaier HJ, Schober R, Fürst G, Mödder U. MRI-guided laser-induced interstitial thermotherapy of cerebral neoplasms. J Comput Assist Tomogr 1994;18(4):519-32. (Pubitemid 24222196)
18. Bettag M, Ulrich F, Schober R, Fürst G, Langen KJ, Sabel M, Kiwit JC. Stereotactic laser therapy in cerebral gliomas. Acta Neurochir Suppl (Wien) 1991;52:81-3.
19. Reimer P, Bremer C, Horch C, Morgenroth C, Allkemper T, Schuierer G. MR-monitored LITT as a palliative concept in patients with high grade gliomas: preliminary clinical experience. J Magn Reson Imaging 1998;8(1):240-4. (Pubitemid 28099585)
20. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62(4):753-64.